UCLA Endocrinology

Home ] Up ] Contents ] Forms ]

Full list of presentations  

 

Lectures and Presentations

  1. Guest Editor, Symposium, "Hypertension and the Kidney", Am. J. Nephrology, 1982.
  2. Invited Symposium Participant: International Symposium on Inactive Renin, Porte Cervo, Italy, May 1982.
  3. Invited Symposium Participant: "Proteases, Potential Role in Health and Disease". Wurzberg, Germany, October 1982.
  4. Chairperson, Endocrine Section, American Federation for Clinical Research, Western Section Meeting, 1983.
  5. Chairperson, Renal Hypertension Section, American Federation for Clinical Research, Western Section Meeting, 1984.
  6. Chairperson, Hypertension Section, International Society of Nephrology Meeting, Los Angeles, 1984.
  7. Chairperson, Hypertension Section, American Federation for Clinical Research, National Meeting, Washington DC, 1985.
  8. Organizing Chairman, Endocrine Section, American Federation for Clinical Research, Western Section of Meeting, 1986.
  9. Organizing Chairman, Hypertension and Clinical Pharmacology, American Federation for Clinical Research, Western Section Meeting, 1987.
  10. Organizing Chairman, Hypertension, American Federation for Clinical Research, National Meeting, San Diego, CA, 1987.
  11. Invited Symposium Participant: "Molecular and Cellular Processes of Hypertension", New Orleans, LA, October 1987.
  12. Invited Discussant at 1988 Gordon Conference on Molecular Mechanisms of Vasoactive Hormones, Oxnard, CA, 1988.
  13. Chairperson, Renin and Vasoactive Hormones, American Society of Hypertension, New York, New York, 1988.
  14. Plenary Lecturer, Southern California Diabetes Association Meeting, Long Beach, CA, 1989.
  15. Guest Speaker, San Diego Cross-town Endocrine Society, 1989.
  16. Symposium Speaker, National Endocrine Society Meeting, Seattle, Washington, 1989.
  17. Guest Speaker, Orange County Cross-town Endocrine Club, 1989.
  18. "Making Biomedical Research a National Priority", Presidential Address, Am. Federation for Clinical Research, 1989.
  19. Organizing Chairperson, Philadelphia Physiologic Society Meeting, Philadelphia, PA, 1990.
  20. Invited Symposium Speaker, Prorenin, International Society of Hypertension, Montreal, Canada, 1990.
  21. Invited Testimony, Senate Appropriations Subcommittee, Biomedical Research, Capitol Hill, Washington DC, 1990.
  22. Invited Speaker, Quebec Society of Nephrology, Annual Meeting, Laurentians, Canada, 1990.
  23. Plenary Speaker, International Society of Hypertension in Pregnancy, "Molecular Biology in Hypertension Research", Perusia, Italy, 1990.
  24. Plenary Lecturer, National Kidney Foundation Meeting, "Insulin and Hypertension", Washington DC, 1990.
  25. Invited Speaker, American Association of Medical Colleges National Meeting, "Meeting the Challenges of a Career Research and the Family", San Francisco, CA, 1990.
  26. Chairman, Session on "Hypertension, Molecular Mechanisms", National American Heart Association Meeting, Dallas, Texas, 1990.
  27. Organizing Chairman, NIH Workshop on Development of Permanent Cell Lines, Bethesda, MD, 1991.
  28. Organizing Chairperson, Hypertension, American Federation for Clinical Research, Seattle, Washington, 1991.
  29. Invited Symposium Speaker, American Society of Hypertension, National Meeting, New York, New York, 1991.
  30. Invited Discussant, Endocrine Society film series, Lifetime Medical Television, Hypertension and Metabolic Issues, 1991.
  31. Chairperson, "Vascular Growth Factors", Council for High Blood Pressure Research, National Meeting, Chicago, 1991.
  32. Sponsor, Finalist Marion Merrill Dow National Fellow Competition for Research in Hypertension, 1991 "Angiotensin II Causes Hypertrophy of Mesangial Cells".
  33. Plenary Lecturer, Southern California American Diabetes Association, Irvine, CA, 1991.
  34. Session Chairman, "Angiotensin II, Growth Differentiation" Angiotensin Gordon Conference, Ventura, CA, 1992.
  35. Organizing Chairperson, Hypertension, National American Federation for Clinical Research Meetings, Baltimore, MD, 1992
  36. NH-MRC Australia, invited consultant for Cardiovascular Research, 1992.
  37. Plenary Speaker, National Kidney Foundation Meetings, Chicago, 1992.
  38. Invited Reviewer, Center for Pediatric Nephrology, Jean Robillard, Ariel Gomez, PI, Charlottesville, VA, July 1992.
  39. Chairperson, plenary session, The Renin-Angiotensin System, Council for High Blood Pressure Research, National Meeting, Cleveland, 1992.
  40. Organizing Symposium Chairperson, "Insulin Resistance and Hypertension" InterAmerican Society of Hypertension Meeting, April 1993.
  41. Working Group on Hypertension in Diabetes, National High Blood Pressure Education Program, NIH, Heart Lung and Blood Institute, 1993.
  42. Meet the Professor, Endocrine Society Meeting, Las Vegas, June 1993.
  43. Symposium Speaker, "Diabetic Vascular Disease", American Diabetes Association Meeting, Las Vegas, June 1993.
  44. Discussion Leader, Angiotensin II Gordon Conference, Oxnard, CA, February 1994.
  45. Invited Speaker, "Insulin, Hypertension and Cardiovascular Disease", Joslin Dedication Proceedings, Boston, MA, April 1994.
  46. Symposium Speaker, American Society of Hypertension, New York, New York, May 1994.
  47. Symposium Speaker, Hanseatic Endocrine Conference, Tissue Prorenin-renin Angiotension Systems, Hamburg, Germany, July 1994.
  48. Organizing Chairperson, Hypertension Sessions, Am. Federation for Clinical Research, Western Section Meeting, Carmel, CA, February 1995.
  49. Symposium Speaker and Chairperson, American Society of Hypertension, New York, New York, May 1995.
  50. Symposium Speaker and Organizer, Endocrine Society, "Tissue effects of Angiotensin II and Implications of AT1 Receptor Blockade", Washington DC, June 1995.
  51. Speaker and Workshop Leader, "Cardiovascular Disease in Women", AHA Hypertension Summer School, Portsmouth, NH, August 1995.
  52. Workshop leader, Council for High Blood Pressure Research, "Workshop on transgenic and knockout animal models in the study of Hypertension and Cardiovascular Disease". American Heart Association, September 1995.
  53. Angiotensin II Gordon Conference Session leader, Angiotensin II and Adhesion molecules, Ventura, CA February 1996.
  54. Invited Symposium Speaker, American Diabetes Association, "Diabetes and Cardiac Remodeling", San Francisco, June 1996.
  55. Invited Speaker, "Lipids and Syndromes of Insulin Resistance" From Molecular Biology to Clinical Medicine. 3rd International Smolence Insulin Symposium, Smolence Castle, Bratislava, Slovak Republic, August 1996.
  56. Session Chairperson, "Renin Angiotensin System", International Vascular Biology Meeting, Seattle, Washington, September 1996.
  57. Best Doctor in California Award, Diabetes, Los Angeles Magazine, Times Newspaper, 1996.
  58. Invited Symposium Speaker, American College of Cardiology, "Insulin resistance and vascular disease", Anaheim, CA, March 1997.
  59. Moderator, Hypertension Symposium, 25th Anniversary Celebration of National Heart Lung and Blood Institute, Santa Monica, CA, March 1997.
  60. Invited Symposium Speaker, Endocrine Society, Angiotensin II and Vascular Remodeling, Minneapolis, June 1997.
  61. Invited Symposium Speaker, Diabetes and Atherosclerosis, American Diabetes Association, Boston, MA, June 1997.
  62. Moderator, Endothelium in Diabetes Symposium, International Federation of Diabetes Meeting, Helsinki, Finland, August 1997.
  63. NIH Workshop Co-chairperson, Cardiac Interstitium, Bethesda, MD, October 1997.
  64. Session Chairperson, NIH Symposium, Bioengineering and Clinical Medicine, Bethesda, MD, February 1998.
  65. Plenary Lecture, Biomedicine ’98, Diabetes is a Vascular Disease, Washington, DC, May 1998.
  66. Plenary Lecture, AII and Diabetic Nephropathy, American Society of Hypertension, New York, NY, May 1998.
  67. Session Chairperson, Epidemiology of Insulin Resistance, American Diabetes Association Meeting, Chicago, June 1998.
  68. Plenary Lecture, Hypertension, Diabetes and Renal Disease, Asian Hypertension Summit, Beijing, China, August 1998.
  69. Plenary Lecture, Heart Disease in Women, National Arthritis and Rheumatology Meeting, San Diego, CA, November 1998.
  70. Rollout of Report of Congressionally Mandated Diabetes Research Working Group (DRWG), Washington, DC, February 1999.
  71. Chairperson, Oral Abstract Session, American Diabetes Association, San Diego, June 1999.
  72. Chairperson, PPARg in the Vasculature, Symposium, American Heart Association, Atllanta, November, 1999.
  73. Plenary Lecturer, PPARg and Atheroslcerosis, Western Society for Clinical Investigation, Carmel CA, February, 2000.
  74. NIDDK Committee to allocate funds to diabetes research, Bethesda, April, 2000.
  75. Chairperson, Oral Abstract Session, American Diabetes Association, San Antonio, June 2000.
  76. Plenary Lecturer, Australian and New Zealand Cardiology Association, Melbourne, August, 2000.
 

 

Home ] Up ]